SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950144-03-003801
Filing Date
2003-03-26
Accepted
2003-03-26 16:09:10
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 NOVEN PHARMACEUTICALS, INC. 12/31/2002 g81253a1e10vkza.htm 10-K/A 903421
3 TRANSACTION AGREEMENT g81253a1exv10w25.txt EX-10.25 321807
4 COMPUTATION OF EARNINGS PER SHARE g81253a1exv11.txt EX-11 1716
5 SUBSIDIARIES g81253a1exv21.txt EX-21 346
6 CONSENT OF DELOITTE & TOUCHE LLP g81253a1exv23w1.txt EX-23.1 826
7 CONSENT OF PRICEWATERHOUSECOOPERS LLP g81253a1exv23w2.txt EX-23.2 549
8 CERTIFICATION OF THE CEO g81253a1exv99w1.txt EX-99.1 1207
9 CERTIFICATION OF THE CFO g81253a1exv99w2.txt EX-99.2 1152
  Complete submission text file 0000950144-03-003801.txt   1233455
Mailing Address 11960 SW 144TH STREET MIAMI FL 33185
Business Address 11960 SW 144TH ST MIAMI FL 33186 3052535099
NOVEN PHARMACEUTICALS INC (Filer) CIK: 0000815838 (see all company filings)

IRS No.: 592767632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-17254 | Film No.: 03618454
SIC: 2834 Pharmaceutical Preparations